Contribution of Toll-like Receptor 9 Signaling to the Acute Inflammatory Response to Nonviral Vectors

Immunostimulatory CpG motifs have been implicated as a major contributor to the acute inflammatory response associated with nonviral vectors, most prominently seen after systemic delivery of cationic lipid-plasmid DNA (pDNA) complexes. We have shown previously that complexes containing pDNA vectors...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hongmei Zhao, Hiraoki Hemmi, Shizuo Akira, Seng H. Cheng, Ronald K. Scheule, Nelson S. Yew
Formatua: Artigo
Hizkuntza:ingelesa
Argitaratua: 2004
Sarrera elektronikoa:https://doi.org/10.1016/j.ymthe.2003.11.012
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
_version_ 1839023272174288896
access_facet Acesso Aberto
author Hongmei Zhao
Hiraoki Hemmi
Shizuo Akira
Seng H. Cheng
Ronald K. Scheule
Nelson S. Yew
author_facet Hongmei Zhao
Hiraoki Hemmi
Shizuo Akira
Seng H. Cheng
Ronald K. Scheule
Nelson S. Yew
cited_by_count_is 83
collection OpenAlex
description Immunostimulatory CpG motifs have been implicated as a major contributor to the acute inflammatory response associated with nonviral vectors, most prominently seen after systemic delivery of cationic lipid-plasmid DNA (pDNA) complexes. We have shown previously that complexes containing pDNA vectors that have been largely depleted of CpG motifs have significantly reduced acute toxicity when delivered systemically. However, several CpGs remain in these vectors and the toxicity is not negligible, especially at higher doses of complex. To determine the maximal reduction in the acute toxic response that could be achieved by eliminating CpG signaling, we injected cationic lipid-pDNA complexes into transgenic mice that are deficient in Toll-like receptor 9 (TLR9), which is the receptor that recognizes immunostimulatory CpG motifs. We observed significantly decreased adverse hematological changes and liver damage in TLR9(-/-) mice compared to normal mice and increased survival at higher doses of complex. However, a pronounced loss of lymphocytes and platelets was still observed in the TLR9(-/-) mice at higher doses. We also measured the toxicity in normal mice of systemically delivered complexes containing non-CpG oligonucleotides. Although serum transaminase levels were reduced, a loss of lymphocytes and platelets akin to that seen in the TLR9(-/-) mice was observed. Taken together, these findings suggest that signaling through TLR9 contributes to the majority but not all of the toxic responses associated with systemic delivery of cationic lipid-pDNA complexes.
format Artigo
frbr_group_id_str doi-10.1016/j.ymthe.2003.11.012
id openalex-W2071110366
institution The University of Osaka
issn_str 1525-0016
issue_str 2
journal_title_str Molecular Therapy
language eng
publishDate 2004
publisher_str Elsevier BV
spellingShingle Contribution of Toll-like Receptor 9 Signaling to the Acute Inflammatory Response to Nonviral Vectors
Hongmei Zhao
Hiraoki Hemmi
Shizuo Akira
Seng H. Cheng
Ronald K. Scheule
Nelson S. Yew
title Contribution of Toll-like Receptor 9 Signaling to the Acute Inflammatory Response to Nonviral Vectors
title_full Contribution of Toll-like Receptor 9 Signaling to the Acute Inflammatory Response to Nonviral Vectors
title_fullStr Contribution of Toll-like Receptor 9 Signaling to the Acute Inflammatory Response to Nonviral Vectors
title_full_unstemmed Contribution of Toll-like Receptor 9 Signaling to the Acute Inflammatory Response to Nonviral Vectors
title_short Contribution of Toll-like Receptor 9 Signaling to the Acute Inflammatory Response to Nonviral Vectors
topic_facet TLR9
Receptor
Toxicity
CpG site
Systemic administration
CpG Oligodeoxynucleotide
Biology
Inflammation
Transfection
Platelet
Molecular biology
Immunology
Chemistry
Cell biology
Biochemistry
In vivo
Gene
Gene expression
Biotechnology
Organic chemistry
DNA methylation
url https://doi.org/10.1016/j.ymthe.2003.11.012
volume_str 9